Corrigendum: The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects β-cells against stress-induced apoptosis [Human Molecular Genetics, 20, 14, (2011), (2823-2833)] doi: 10.1093/hmg/ddr193;The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects β-cells against stress-induced apoptosis

Human Molecular Genetics

Volumn 20, Issue 14, 2011, Pages 2823-2833

  Baquié, Mathurin ^a,g   St Onge, Luc ^b   Kerr Conte, Julie ^b   Cobo Vuilleumier, Nadia ^g   Lorenzo, Petra I ^g   Jimenez Moreno, Carmen M ^g   Cederroth, Christopher R ^a,h   Nef, Serge ^a   Borot, Sophie ^d   Bosco, Domenico ^d   Wang, Haiyan ^e   Marchetti, Piero ^f   Pattou, Francois ^c   Wollheim, Claes B ^a   Gauthier, Benoit R ^g  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b Lille University Hospital ^*

^c UNIV LILLE   (France)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e F HOFFMANN LA ROCHE LTD   (Switzerland)

^f CISANELLO HOSPITAL   (Italy)

^g CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^h ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CELL ANTIGEN; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYCLIN D1; CYCLIN E1; CYP11B1; CYTOCHROME; CYTOKINE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOCORTICOID; GLUCOSE; INSULIN; LIVER RECEPTOR HOMOLOG 1; PROTEIN BCL XL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RELEASE; MALE; MODULATION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

RATTUS;

EID: 79959781820     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddx402     Document Type: Erratum

References (47)

1. Roglic, G., Unwin, N., Bennett, P.H., Mathers, C., Tuomilehto, J., Nag, S., Connolly, V. and King, H. (2005) The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care, 28, 2130-2135.
2. Calcutt, N.A., Cooper, M.E., Kern, T.S. and Schmidt, A.M. (2009) Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials. Nat. Rev. Drug Discov., 8, 417-429.
3. Butler, A.E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R.A. and Butler, P.C. (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes, 52, 102-110.
4. Rausa, F., Samadani, U., Ye, H., Lim, L., Fletcher, C., Jenkins, N., Copeland, N. and Costa, R. (1997) The cut-homeodomain transcriptional activator HNF-6 is coexpressed with its target gene HNF-3 beta in the developing murine liver and pancreas. Dev. Biol., 92, 228-246.
5. Pare, J.F., Roy, S., Galarneau, L. and Belanger, L. (2001) The mouse fetoprotein transcription factor (FTF) gene promoter is regulated by three GATA elements with tandem E box and Nkx motifs, and FTF in turn activates the Hnf3beta, Hnf4alpha, and Hnf1alpha gene promoters. J. Biol. Chem., 276, 13136-13144.
6. Heng, J.C., Feng, B., Han, J., Jiang, J., Kraus, P., Ng, J.H., Orlov, Y.L., Huss, M., Yang, L., Lufkin, T. et al. (2010) The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell, 6, 167-174.
7. Galarneau, L., Pare, J.F., Allard, D., Hamel, D., Levesque, L., Tugwood, J.D., Green, S. and Belanger, L. (1996) The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Mol. Cell. Biol., 16, 3853-3865.
8. Botrugno, O.A., Fayard, E., Annicotte, J.S., Haby, C., Brennan, T., Wendling, O., Tanaka, T., Kodama, T., Thomas, W., Auwerx, J. et al. (2004) Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol. Cell, 15, 499-509.
9. Boerboom, D., Pilon, N., Behdjani, R., Silversides, D.W. and Sirois, J. (2000) Expression and regulation of transcripts encoding two members of the NR5A nuclear receptor subfamily of orphan nuclear receptors, steroidogenic factor-1 and NR5A2, in equine ovarian cells during the ovulatory process. Endocrinology, 141, 4647-4656.
10. Lee, Y.K. and Moore, D.D. (2008) Liver receptor homolog-1, an emerging metabolic modulator. Front. Biosci., 13, 5950-5958.
11. Fayard, E., Schoonjans, K., Annicotte, J.S. and Auwerx, J. (2003) Liver receptor homolog 1 controls the expression of carboxyl ester lipase. J. Biol. Chem., 278, 35725-35731.
12. Rausa, F.M., Galarneau, L., Belanger, L. and Costa, R.H. (1999) The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3beta in the developing murine liver intestine. Mech. Devel., 89, 185-188.
13. Annicotte, J.S., Fayard, E., Swift, G.H., Selander, L., Edlund, H., Tanaka, T., Kodama, T., Schoonjans, K. and Auwerx, J. (2003) Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development. Mol. Cell. Biol., 23, 6713-6724.
14. Chuang, J.C., Cha, J.Y., Garmey, J.C., Mirmira, R.G. and Repa, J.J. (2008) Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol. Endocrinol., 22, 2353-2363.
15. Ortlund, E.A., Lee, Y., Solomon, I.H., Hager, J.M., Safi, R., Choi, Y., Guan, Z., Tripathy, A., Raetz, C.R., McDonnell, D.P. et al. (2005) Modulation of human nuclear receptor LRH-1 activity by phospholipids and SHP. Nat. Struct. Mol. Biol., 12, 357-363.
16. Whitby, R.J., Dixon, S., Maloney, P.R., Delerive, P., Goodwin, B.J., Parks, D.J. and Willson, T.M. (2006) Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. J. Med. Chem., 49, 6652-6655.
17. Wang, S.L., Zheng, D.Z., Lan, F.H., Deng, X.J., Zeng, J., Li, C.J., Wang, R. and Zhu, Z.Y. (2008) Increased expression of hLRH-1 in human gastric cancer and its implication in tumorigenesis. Mol. Cell. Biochem., 308, 93-100.
18. Wang, S., Lan, F., Huang, L., Dong, L., Zhu, Z., Li, Z., Xie, Y. and Fu, J. (2005) Suppression of hLRH-1 mediated by a DNA vector-based RNA interference results in cell cycle arrest and induction of apoptosis in hepatocellular carcinoma cell BEL-7402. Biochem. Biophys. Res. Commun., 333, 917-924.
19. Annicotte, J.S., Chavey, C., Servant, N., Teyssier, J., Bardin, A., Licznar, A., Badia, E., Pujol, P., Vignon, F., Maudelonde, T. et al. (2005) The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene, 24, 8167-8175.
20. Venteclef, N., Smith, J.C., Goodwin, B. and Delerive, P. (2006) Liver receptor homolog 1 is a negative regulator of the hepatic acute-phase response. Mol. Cell. Biol., 26, 6799-6807.
21. Coste, A., Dubuquoy, L., Barnouin, R., Annicotte, J.S., Magnier, B., Notti, M., Corazza, N., Antal, M.C., Metzger, D., Desreumaux, P. et al. (2007) LRH-1-mediated glucocorticoid synthesis in enterocytes protects against inflammatory bowel disease. Proc. Natl. Acad. Sci. USA, 104, 13098-13103.
22. Venteclef, N. and Delerive, P. (2007) Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response. J. Biol. Chem., 282, 4393-4399.
23. Contreras, J.L., Smyth, C.A., Bilbao, G., Young, C.J., Thompson, J.A. and Eckhoff, D.E. (2002) 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation, 74, 1252-1259.
24. Liu, S., Le May, C., Wong, W.P., Ward, R.D., Clegg, D.J., Marcelli, M., Korach, K.S. and Mauvais-Jarvis, F. (2009) Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes, 58, 2292-2302.
25. Le May, C., Chu, K., Hu, M., Ortega, C.S., Simpson, E.R., Korach, K.S., Tsai, M.J. and Mauvais-Jarvis, F. (2006) Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. USA, 103, 9232-9237.
26. Thiruchelvam, P.T., Lai, C.F., Hua, H., Thomas, R.S., Hurtado, A., Hudson, W., Bayly, A.R., Kyle, F.J., Periyasamy, M., Photiou, A. et al.. (2010) The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells. Breast Cancer Res. Treat., 127, 385-396.
27. Moertel, C.G., Hanley, J.A. and Johnson, L.A. (1980) Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma. N. Engl. J. Med., 303, 1189-1194.
28. Galluzzi, L., Aaronson, S.A., Abrams, J., Alnemri, E.S., Andrews, D.W., Baehrecke, E.H., Bazan, N.G., Blagosklonny, M.V., Blomgren, K., Borner, C. et al. (2009) Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell. Death. Differ., 16, 1093-1107.
29. Lisurek, M. and Bernhardt, R. (2004) Modulation of aldosterone and cortisol synthesis on the molecular level. Mol. Cell. Endocrinol., 215, 149-159.
30. Lund, T., Fosby, B., Korsgren, O., Scholz, H. and Foss, A. (2008) Glucocorticoids reduce pro-inflammatory cytokines and tissue factor in vitro and improve function of transplanted human islets in vivo. Transpl. Int., 21, 669-678.
31. Yang, F.M., Pan, C.T., Tsai, H.M., Chiu, T.W., Wu, M.L. and Hu, M.C. (2009) Liver receptor homolog-1 localization in the nuclear body is regulated by sumoylation and cAMP signaling in rat granulosa cells. FEBS J., 276, 425-436.
32. Levin, E.R. (2008) Rapid signaling by steroid receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol., 295, R1425-R1430.
33. Schoonjans, K., Dubuquoy, L., Mebis, J., Fayard, E., Wendling, O., Haby, C., Geboes, K. and Auwerx, J. (2005) Liver receptor homolog 1 contributes to intestinal tumor formation through effects on cell cycle and inflammation. Proc. Natl. Acad. Sci. USA, 102, 2058-2062.
34. Lee, S.H., Demeterco, C., Geron, I., Abrahamsson, A., Levine, F. and Itkin-Ansari, P. (2008) Islet specific Wnt activation in human type II diabetes. Exp. Diabetes Res., 2008, 728763.
35. Yi, F., Brubaker, P.L. and Jin, T. (2005) TCF-4 mediates cell type-specific regulation of proglucagon gene expression by beta-catenin and glycogen synthase kinase-3beta. J. Biol. Chem., 280, 1457-1464.
36. Rhen, T. and Cidlowski, J.A. (2005) Antiinflammatory action of glucocorticoids-new mechanisms for old drugs. N. Engl. J. Med., 353, 1711-1723.
37. Delaunay, F., Khan, A., Cintra, A., Davani, B., Ling, Z.C., Andersson, A., Ostenson, C.G., Gustafsson, J., Efendic, S. and Okret, S. (1997) Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J. Clin. Invest., 100, 2094-2098.
38. Lambillotte, C., Gilon, P. and Henquin, J.C. (1997) Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets. J. Clin. Invest., 99, 414-423.
39. Shapiro, A., Lakey, J., Ryan, E., Korbutt, G., Toth, E., Warnock, G., Keneteman, N. and Rajotte, R. (2000) Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Engl. J. Med., 343, 230-238.
40. Cobo-Vuilleumier, N. and Gauthier, B.R. (2010) To b-e or not to b-e replicating after 30: retrospective dating of human pancreatic islets. J. Clin. Endocrinol. Metab., 95, 4552-4554.
41. Perl, S., Kushner, J.A., Buchholz, B.A., Meeker, A.K., Stein, G.M., Hsieh, M., Kirby, M., Pechhold, S., Liu, E.H., Harlan, D.M. et al. (2010) Significant human {beta}-Cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating. J. Clin. Endocrinol. Metab., 95, E234-E239.
42. Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P. and Mark, M. (2000) Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development, 127, 4277-4291.
43. Gauthier, B.R., Brun, T., Sarret, E.J., Ishihara, H., Schaad, O., Descombes, P. and Wollheim, C.B. (2004) Oligonucleotide microarray analysis reveals PDX1 as an essential regulator of mitochondrial metabolism in rat islets. J. Biol. Chem., 279, 31121-31130.
44. Kirkpatrick, C.L., Marchetti, P., Purrello, F., Piro, S., Bugliani, M., Bosco, D., de Koning, E.J., Engelse, M.A., Kerr-Conte, J., Pattou, F. et al. (2010) Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors. PLoS One, 5, e11053.
45. Merglen, A., Theander, S., Rubi, B., Chaffard, G., Wollheim, C.B. and Maechler, P. (2004) Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells. Endocrinology, 145, 667-678.
46. Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P.A. and Wollheim, C.B. (1992) Establishment of 2-mercaptoethanol-dependent differentiated insulin- secreting cell lines. Endocrinology, 130, 167-178.
47. Brun, T., Franklin, I., St-Onge, L., Biason-Lauber, A., Schoenle, E., Wollheim, C.B. and Gauthier, B.R. (2004) The diabetes-linked transcription factor Pax4 promotes beta-cell proliferation and survival in rat and human islets. J. Cell. Biol., 167, 1123-1135.